New Product
Commercialization
Focus commercialization pathways on your perfect product-market fit and pinpoint market opportunities with precision.
MORE
Growth
Acceleration
Supercharge your commercial teams with comprehensive, up-to-date market and customer intelligence to rapidly scale market impact.
MORE
Market Segments
Medtech Diagnostics Digital Health Drug Delivery BioPharma
About

S2N Health:
Your Partner In MedTech
Commercial Success

S2N Health: Your Partner In MedTech Commercial Success

Established in 2011, S2N Health propels go-to-market and growth strategies through value-maximizing commercial intelligence solutions.

We have collaborated with over 180 companies, ranging from startups to global enterprises, delivering tailored analytics and valuable insights that shape pivotal product, commercial, and business decisions. Our approach involves merging deep domain expertise in medtech, diagnostics, digital health, and drug delivery with enhanced market and customer data, unlocking the full potential of our clients’ innovations.

In 2021, S2N Health launched RepSignal—an advanced AI-powered commercial intelligence platform for healthcare technology companies. Deploying leading-edge AI algorithms, RepSignal efficiently consolidates vast amounts of healthcare data and translates them into actionable insights for commercial teams and other stakeholders. RepSignal provides effective end-to-end solutions for any stage in the commercial lifecycle, from pre-launch to M&A. Customers can use RepSignal as stand-alone platform or seamlessly integrated into Salesforce.com, Hubspot, other CRM, or analytics platform.

Meet Our Leadership Team

Amy Siegel
CEO & Co-Founder
Amy's extensive involvement in the medtech industry and deep insights about propelling market impact played a pivotal role in shaping the development of RepSignal, our end-to-end SAAS solution for healthcare technology companies.
Tim Kofol
CTO & Co-Founder
Tim has spearheaded the distinctive architecture and algorithms that underpin RepSignal's data consolidation and advanced AI-powered analytics, a leading-edge solution at the intersection of healthcare and technology.
Katie Grimm
Vice President of Sales
Katie’s experience and leadership in navigating sophisticated software products and complex sales landscapes and her commitment to cultivating lasting partnerships have seamlessly integrated her into the S2N Health team.
Kelsey Hirsch
Senior Director of Product
Kelsey has led the development of our RepSignal platform since its inception. Kelsey manages our product life cycles and creates roadmaps to outline the vision and goals for ongoing product development.
Krista Kett
Director of Operations
Krista has been part of S2N Health from the very beginning. Her positivity, resourcefulness, and ability to respond quickly to unique situations and problems has helped grow the company to where we are today.

Board of Directors

Martha Shadan
Advisor & Board Member At
Various MedTech Companies
Former President & CEO of Miach Orthopaedics and Rotation Medical. Global VP of Marketing at Smith & Nephew, following the acquisition of Rotation Medical.
Andrew Schwab
Managing Partner of Excelerate Health Ventures
C-level executive in building and growing technology-focused companies, spanning software development and personalized medicine.
Ren Roome
Partner of Boston Millennia Partners
Venture capital and growth capital expert with main focus on medtech and life sciences. Various board-level involvements in healthcare technology companies nationwide.
Dan Coppens (Observer)
Member of Robin Hood Ventures
Entrepreneur, investor, and startup mentor. Co-founder, CEO, and CTO of Qfix which became CQ Medical through a merger with CIVCO Radiotherapy.
Amy Siegel
Co-Founder & CEO of S2N Health
Extensive involvement in the medtech industry fueled the development of the RepSignal SAAS solution, providing critical market intelligence for healthcare technology companies.
Tim Kofol
Co-Founder & CTO of S2N Health
Data science and deep knowledge of the medtech industry underpin RepSignal's data transformation and advanced AI-powered market intelligence solution.

Advisors

John D’Amore
CEO
More Informatics
Strategic Advisor, Director, and former President & Strategy Officer at Diameter Health.
Bruce Shook
Serial MedTech
Entrepreneur
Former CEO of Neuronetics, serves on several medtech company boards, two exits to Philips.
Dave Roberts
President U.S. Market
Medtronic, retired
39-year commercial leadership career with Medtronic spanning multiple operating units.
Howard Rosen
CEO
Evident Vascular
Former Sales & Marketing Leadership roles at Vesper Medical, Intact Vascular & Boston Scientific.
Matthew Bellows
General Partner
Grit Capital Partners
Former VP Business Development at Amex, Founder of Yesware, Bodeswell, and WGR Media.
Dr. Edward Kerslake
Investor & Board Member
MedTech, IT & Pharma
Management Advisor and Board Member at GI Scientific and Allurion. Former CEO of Topera Medical.
David Pierce
EVP & President, Boston Scientific MedSurg (retired)
Senior executive across Boston Scientific divisions. Advisor & board member at multiple companies.